[Federal Register Volume 63, Number 136 (Thursday, July 16, 1998)]
[Notices]
[Page 38424]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-18895]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated January 21, 1998, and published in the Federal 
Register on February 12, 1998, (63 FR 7181), Knoll Pharmaceutical 
Company, 30 North Jefferson Road, Whippany, New Jersey 07981, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I                          
Hydromorphone (9150).......................  II                         
------------------------------------------------------------------------

    The firm plans to produce bulk product and finished dosage units 
for distribution to its customers.
    DEA has considered the factors in 21 U.S.C. 823(a) and determined 
that the registration of Knoll Pharmaceutical Company to manufacture 
the listed controlled substances is consistent with the public interest 
at this time. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: June 30, 1996.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-18895 Filed 7-15-98; 8:45 am]
BILLING CODE 4410-09-M